Although the more marked glycemic phenotype of global versus β cell-selective StarD10 mice might appear to suggest an action of T2D-associated variants at the ARAP1/STARD10 locus via the liver or other insulin-sensitive tissues, several lines of evidence point away from this possibility. The gene discussed is ARAP1; the disease is type 2 diabetes mellitus.